1. Home
  2. STELLA PHARMA NEWS
STELLA PHARMA NEWS
December 6th, 2023

Encounter with Director of Cancer Research Center of Lyon, and Team of Centre Léon Bérard at French Embassy

Business France Japan Office of the French Embassy in Japan engages in building……

READ MORE

September 29th, 2022

Groundbreaking Ceremony for the Hainan BNCT Center

On 25th September, the Groundbreaking Ceremony for the Boao BNCT center has tak……

READ MORE

September 27th, 2022

Stella Pharma Presented at Side Events of the 66th IAEA General Conference

The 66th International Atomic Energy Agency (IAEA) General Conference is being ……

READ MORE

June 24th, 2022

Notice Regarding Our First Overseas Introduction of BNCT in the Hainan Medical Tourism Pilot Zone, China

Sumitomo Heavy Industries, Ltd. and STELLA PHARMA CORPORATION have respectively……

READ MORE

April 7th, 2022

Stella Pharma Corporation was nominated as a finalist of the Informa Pharma Intelligence Awards Japan 2022

Informa Pharma Intelligence has announced that Stella Pharma is a nominee f……

READ MORE

February 18th, 2022

“Destroying Cancer with Boron and Neutrons” will be on NHK WORLD-JAPAN

Japan's public media organization NHK (Japan Broadcasting Corporation) will bro……

READ MORE

October 21st, 2021

Interview published on Science Japan, online magazine| Japan’s “Fifth Cancer Treatment,” BNCT, Finally Off the Ground

Here is a featured story on BNCT (Boron Neutron Capture Therapy) boron drug dev……

READ MORE

June 23rd, 2021

The phase II study of recurrent glioblastoma in Japan has published in “Neuro-Oncology Advances”

The title is “Accelerator-based BNCT for patients with recurrent glioblastoma: ……

READ MORE

December 9th, 2020

The phase II study of recurrent or locally advanced head and neck cancer in Japan has published in “Radiotherapy and Oncology”

The title is "Boron neutron capture therapy using cyclotron-based epithermal ne……

READ MORE

May 19th, 2020

STELLA PHARMA will launch Steboronine®, the World’s First BNCT Drug, on May 20, 2020

STELLA PHARMA CORPORATION (Head office: Chuoku, Osaka City; President: Tomoyuki……

READ MORE

March 25th, 2020

STELLA PHARMA Receives Marketing and Manufacturing Approval in Japan for “Steboronine® Intravenous Drip Bag 9000mg/300mL

STELLA PHARMA CORPORATION (Head office: Chuo-ku, Osaka City, President: Tomoyuk……

READ MORE

January 23rd, 2020

How to keep boron inside cells during radiotherapy: a simple novel approach to cancer treatment

Boron neutron capture therapy (BNCT) is a technique in which p‐boronophenylalan……

READ MORE